Literature DB >> 31188172

Comparing Postoperative Analgesic Effect of Dexmedetomidine or Dexamethasone Added to Lidocaine Through Infraclavicular Block in Forearm Surgery.

Siamak Yaghoobi1, Hoda Shahamat, Ali Alizadeh, Marzieh Beigom Khezri.   

Abstract

OBJECTIVE: The objective of this study was to compare the analgesic efficacy of dexamethasone versus dexmedetomidine added to lidocaine using infraclavicular block in patients undergoing forearm fracture surgery.
METHOD: Seventy-five patients aged 20 to 60 years were recruited for a prospective, double-blinded, randomized clinical trial. Ultrasound-guided infraclavicular brachial plexus block was performed in 3 groups by injecting 28 mL lidocaine plus 2 mL distilled water (Lido), 28 mL lidocaine plus 2 mL (8 mg) dexamethasone (Dexa), and 28 mL lidocaine plus 2 mL (1 µg/kg) dexmedetomidine (Dexm). Sensory and motor block onset time and the duration, hemodynamic variables, the time for the first analgesic request, and the total analgesic agents consumed within 6 hours after infraclavicular block were assessed.
RESULTS: Sensory block duration in the Dexm group was significantly greater than in the Lido (P=0.019) and Dexa (P=0.046) groups. The mean motor block duration in the Dexm group showed to be significantly longer than that in the Lido group (P=0.009). Pain intensity within 4 hours after block significantly increased in the Lido group compared with that in the Dexa and Dexm groups (P=0.001). Analgesic consumption during 6 hours after the procedure was higher in the Lido group when compared with the other 2 groups (P=0.001). The Dexm group showed the highest reduction in the mean arterial pressure (P=0.006) and heart rate (P=0.001) among the 3 groups.
CONCLUSIONS: There was no significant difference in postoperative pain intensity between the Dexa and Dexm groups, although DEXm demonstrated a longer sensory block duration in comparison with dexamethasone as a lidocaine adjuvant in infraclavicular block.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31188172     DOI: 10.1097/AJP.0000000000000736

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  6 in total

1.  Ropivacaine with Dexmedetomidine or Dexamethasone in a Thoracic Paravertebral Nerve Block Combined with an Erector Spinae Plane Block for Thoracoscopic Lobectomy Analgesia: A Randomized Controlled Trial.

Authors:  Jing Yang; Min Zhao; Xiao-Rui Zhang; Xiao-Rui Wang; Zhi-Hao Wang; Xiao-Yue Feng; Ya-Juan Lei; Jian-Wen Zhang
Journal:  Drug Des Devel Ther       Date:  2022-05-26       Impact factor: 4.319

Review 2.  A Comprehensive Review and Update of the Use of Dexmedetomidine for Regional Blocks.

Authors:  Ivan Urits; Celina Guadalupe Virgen; Hamed Alattar; Jai Won Jung; Amnon A Berger; Hisham Kassem; Islam Mohammad Shehata; Amir Elhassan; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-10-15

Review 3.  Comparison of postoperative analgesic effects in response to either dexamethasone or dexmedetomidine as local anesthetic adjuvants: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Zhen-Guo Song; Shen-Yue Pang; Gui-Yue Wang; Zhao Zhang
Journal:  J Anesth       Date:  2021-01-30       Impact factor: 2.078

4.  The Effects of Magnesium Sulfate with Lidocaine for Infraclavicular Brachial Plexus Block for Upper Extremity Surgeries.

Authors:  Siavash Beiranvand; Arash Karimi; Majid Haghighat Shoar; Maryam Baghizadeh Baghdashti
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2020-11-06

5.  Optimal dose of perineural dexmedetomidine to prolong analgesia after brachial plexus blockade: a systematic review and Meta-analysis of 57 randomized clinical trials.

Authors:  Hai Cai; Xing Fan; Pengjiu Feng; Xiaogang Wang; Yubo Xie
Journal:  BMC Anesthesiol       Date:  2021-09-28       Impact factor: 2.217

6.  Efficacy of Dexamethasone versus Dexmedetomidine Combined with Local Anaesthetics in Brachial Plexus Block: A Meta-Analysis and Systematic Review.

Authors:  Ming Li; Pinghu Zhang; Duangao Wei
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-01       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.